Regeneron Pharmaceuticals Inc. buy Citigroup Inc.
Start price
02.06.25
/
50%
€428.20
Target price
02.06.26
€571.68
Performance (%)
19.83%
End price
03.06.26
€513.10
Summary
This prediction ended on 03.06.26 with a price of €513.10. The BUY prediction by Citigroup_Inc_ finished with a performance of 19.83%. Citigroup_Inc_ has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. A total of €3.64 was paid as dividends for this prediction. Citigroup_Inc_ has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | -4.064% | -4.064% | 15.408% |
| iShares Core DAX® | 0.271% | 1.796% | 4.850% |
| iShares Nasdaq 100 | 1.884% | 2.153% | 37.074% |
| iShares Nikkei 225® | 3.579% | 5.306% | 58.395% |
| iShares S&P 500 | 0.151% | 1.090% | 25.282% |
Comments by Citigroup_Inc_ for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target lowered by analysts at Citigroup Inc. from $700.00 to $650.00. They now have a "buy" rating on the stock.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€478.90
13.10.25
13.10.25
€568.00
13.10.26
13.10.26
11.27%
15:40
15:40
Stopped prediction by Citigroup_Inc_ for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€562.80
29.10.25
29.10.25
€600.95
29.10.26
29.10.26
-5.32%
15:40
15:40
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€519.80
14.05.25
14.05.25
€625.59
14.05.26
14.05.26
17.99%
15.05.26
15.05.26